Zoetis Gets Conditional License From USDA
Zoetis Gets Conditional License From USDA for Bird Flu Vaccine
Zoetis said the U.S. Department of Agriculture's Center for Veterinary Biologics issued the company a conditional license for its Avian Influenza Vaccine, H5N2 Subtype, Killed Virus. The vaccine is labeled for use in chickens, the company said.
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Shares of Zoetis (NYSE: ZTS), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...
BofA lowered the firm’s price target on Zoetis (ZTS) to $200 from $205 and keeps a Buy rating on the shares. Zoetis reported “solid” Q4 results ...
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Q4 2024 Earnings Call Feb 13, 2025, 8:30 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.
Hosted on MSN1d
Why Zoetis (ZTS) Shares Are Falling TodayWhat Happened? Shares of animal health company Zoetis (NYSE:ZTS) fell 10.6% in the morning session after the company reported ...
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback